Semaglutide offers a promising option for individuals struggling with weight loss
En trminos simples, acta como un vehculo que permite que determinadas grasas lleguen al lugar donde se transforman en energa
Approved indications across the class span type 2 diabetes, chronic weight management for products such as Wegovy, Saxenda, and Zepbound, cardiovascular risk reduction in type 2 diabetes, and obstructive sleep apnea in adults with obesity for Zepbound as of 2024
Patients, along with a physician's guidance whenever possible, must weigh the benefits, risks, and costs of both or any combination thereof
A new method for measuring daytime sleepiness: the Epworth sleepiness scale